The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With Schizophrenia
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: solution-oriented approach program.
- Who it may be relevant to
- Registry conditions: SCHIZOPHRENIA 1 (Disorder), Psychosocial Adaptation, Treatment Adherence. Basic parameters: 18 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The aim of this study is to evaluate the effects of a solution-focused approach-based individual intervention on psychosocial adjustment and treatment adherence in individuals diagnosed with schizophrenia. The study will be conducted as a randomized controlled trial including 60 clinically stable individuals diagnosed with schizophrenia according to DSM-5 criteria and registered at a Community Mental Health Center affiliated with a university hospital. Participants will be randomly assigned to an experimental group (n=30) and a control group (n=30). The experimental group will receive one individual solution-focused therapy session per week for six weeks. The control group will receive usual care only. Data will be collected using a Personal Information Form, the Psychosocial Adjustment Scale (PSSAS), and the Medication Adherence Scale (MARS).
Detailed description
Objective:
Schizophrenia is a chronic psychiatric disorder that significantly affects thought, emotion, and behavior, often limiting social functioning, treatment adherence, and integration into daily life. There is an increasing need for person-centered, empowering, and brief intervention models in psychiatric nursing. This study aims to determine the effects of a solution-focused approach (SFA)-based individual intervention on psychosocial adjustment and treatment adherence in individuals with schizophrenia.
Study Design:
This research will use a pretest-posttest randomized controlled experimental design with a control group.
Study Population:
The study will include 60 individuals diagnosed with schizophrenia according to DSM-5 diagnostic criteria, considered clinically stable, and registered at a Community Mental Health Center affiliated with a university hospital in Türkiye. Participants will be randomly assigned to an experimental group (n=30) or a control group (n=30) using computer-assisted randomization.
Intervention:
Experimental Group: Participants will receive individual solution-focused therapy sessions once per week for six consecutive weeks. The sessions will emphasize individual strengths, recall positive coping experiences, support future goal setting, and provide guidance on repeating effective solutions.
Control Group: Participants will receive no additional intervention beyond usual care.
Outcome Measures:
Data will be collected with the following instruments:
Personal Information Form
Psychosocial Adjustment Scale (PSSAS)
Medication Adherence Scale (MARS)
Statistical Analyses:
Planned analyses will include independent samples t-tests, paired t-tests, and ANCOVA.
Interventions
- Behavioral solution-oriented approach program
The solution-focused nursing intervention applied to the experimental group in the study was planned as individual sessions, consisting of one session per week, lasting a total of six weeks. The interventions were based on the principles of solution-focused brief therapy, focusing on the individual's strengths, past coping experiences, and current resources. The interviews aimed to identify exceptions, build positive future expectations, set small but achievable goals, strengthen hope, and incre
Primary outcome measures
- pretest (6-week solution-focused approach before the intervention) [Time frame: Baseline (1 week before intervention)]]
- pretest (6-week solution-focused approach before the intervention) [Time frame: Baseline (within 1 week before intervention)]
Secondary outcome measures (2)
- posttest (After the 6-week solution-focused approach intervention) [Time frame: 6 weeks after baseline (post-intervention)]
- posttest (After the 6-week solution-focused approach intervention) [Time frame: Post-intervention (6 weeks after completion of the intervention)]
Eligibility criteria
Inclusion criteria
- Having been diagnosed with schizophrenia according to DSM-5 diagnostic criteria,
Being between 18 and 65 years of age,
Being literate and verbally communicative,
Being clinically stable (not exhibiting symptoms of acute psychosis),
Being registered with a Community Mental Health Center (CMHC) and receiving regular services,
Being cognitively competent enough to participate in individual interviews during the research process,
Being an individual currently receiving psychiatric treatment and taking medication,
Agreeing to participate voluntarily in the study and signing a written informed consent form.
Exclusion criteria
- those who do not meet the inclusion criteria
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Supportive care
Study locations
Turkey (Türkiye) · 1 center
- Community Mental Health Center — Muş
Identifiers
NCT: NCT07144592 · 167678